Clinical accuracy and safety using the synchromed II intrathecal drug infusion pump

Regional Anesthesia and Pain Medicine

Volumn 39, Issue 4, 2014, Pages 341-346

  Wesemann, Kelly ^a   Coffey, Robert J ^a   Wallace, Mark S ^b   Tan, Ye ^a   Broste, Steven ^a   Buvanendran, Asokumar ^c  

^a MEDTRONIC INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; MORPHINE;

ACCURACY; ADULT; AGED; ARTICLE; CHRONIC PAIN; DEVICE SAFETY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG WITHDRAWAL; FEMALE; FLOW RATE; HUMAN; IMPLANT SITE EFFUSION; IMPLANT SITE INFECTION; IMPLANT SITE INFLAMMATION; IMPLANTABLE PUMP; INFUSION PUMP; INTRATHECAL DRUG ADMINISTRATION; LETHARGY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; NAUSEA; PACKAGING; PAIN; POSTDURAL PUNCTURE HEADACHE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESIDUAL VOLUME; SPASTICITY; SYRINGE; UNITED STATES; VERY ELDERLY; VOMITING; BIOASSAY; EVALUATION STUDY; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; MUSCLE SPASTICITY; PATIENT SAFETY; REPRODUCIBILITY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ENDPOINT DETERMINATION; FEMALE; HUMANS; INFUSION PUMPS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MUSCLE SPASTICITY; PAIN; PATIENT SAFETY; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84903200392     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0000000000000107     Document Type: Article

References (17)

1. Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clinic Proc. 1981;56:516-520.
2. Turner JA, Sears JM, Loeser JD. Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications. Clin J Pain. 2007;23:180-195. (Pubitemid 46145465)
3. Wallace MS, Charapata SG, Fisher R, et al. Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial. Neuromodulation. 2006;9:75-86.
4. Gilmartin R, Bruce D, Storrs BB, et al. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol. 2000;15:71-77. (Pubitemid 30139867)
5. Meythaler JM, DeVivo MJ, Hadley M. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil. 1996;77:461-466. (Pubitemid 26158168)
6. Nance P, Schryvers O, Schmidt B, et al. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci. 1995;22:22-29.
7. Coffey RJ, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993;78:226-232. (Pubitemid 23039122)
8. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992;77:236-240.
9. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl JMed. 1989;320:1517-1521. (Pubitemid 19145803)
10. Watve SV, Sivan M, Raza WA, Jamil FF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord. 2012;50: 107-111.
11. Prager J, Deer T, Levy R, et al. 2014. Best practices for intrathecal drug delivery for pain. Neuromodulation. 2014; E-pub ahead of print. DOI: 10.1111/ner.12146.
12. Rauck R, Deer T, Rosen S, et al. 2012. Long-term follow-up of a novel implantable programmable infusion pump. Neuromodulation. 2013;16: 163-167.
13. Venugopalan R, Ginggen A, Bork T, Anderson W, Buffen E. 2011. In vivo study of flow-rate accuracy of the MedStream Programmable Infusion System. Neuromodulation. 2011;14:235-241.
14. Rauck R, Deer T, Rosen S, et al. Accuracy and efficacy of intrathecal administration of morphine sulfate for treatment of intractable pain using the Prometra Programmable Pump. Neuromodulation. 2010; 13:102-108.
15. Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel V. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 2011;14:219-248.
16. Atli A, Theodore BR, Turk DC, Loeser JD. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up. Pain Med. 2010;11:1010-1016.
17. Flückiger B, Knecht H, Grossmann S, Felleiter P. Device-related complications of long-term intrathecal drug therapy via implanted pumps. Spinal Cord. 2008;46:639-643.